Related Experiment Video
Updated: Dec 18, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Pre-hospital point-of-care troponin measurement: a clinical example of its additional value
G W A Aarts1, K van der Wulp1, C Camaro2
1Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Insights
Early detection of acute coronary syndrome (ACS) using point-of-care troponin and the HEART score in the pre-hospital setting can identify low-risk patients. This approach may reduce emergency department visits and enable timely treatment for high-risk individuals.
Area of Science:
- Cardiology
- Emergency Medicine
- Diagnostic Testing
Background:
- Acute coronary syndrome (ACS) requires prompt recognition to minimize myocardial ischemia risks.
- Current pre-hospital protocols often lack ACS rule-out capabilities, leading to emergency department (ED) transport for suspected cases.
- The HEART score is utilized in EDs to assess the risk of major adverse cardiac events (MACE).
Purpose of the Study:
- To explore the potential advantages of pre-hospital point-of-care (POC) troponin measurement and HEART score assessment for early ACS detection.
- To highlight the benefits of identifying high-risk patients and potentially ruling out ACS before hospital arrival.
- To discuss the implications of pre-hospital ACS rule-out for reducing unnecessary ED visits.
Main Methods:
- Utilizing point-of-care (POC) troponin measurements by ambulance paramedics.
- Calculating the HEART score in the pre-hospital setting based on POC troponin results and clinical parameters.
- Reviewing the potential impact of these pre-hospital assessments on patient management and healthcare resource utilization.
Main Results:
- POC troponin measurement allows paramedics to calculate the HEART score pre-hospital.
- This enables early identification of patients at low risk for MACE.
- Potential for early recognition of ACS and identification of high-risk patients prior to ED arrival.
Conclusions:
- Pre-hospital POC troponin and HEART score assessment offer significant advantages for early ACS detection.
- This strategy can facilitate timely treatment initiation and potentially prevent unnecessary emergency department visits.
- The ARTICA trial is investigating the safety and cost-effectiveness of referring low-risk patients to general practitioners.
Abstract:
In the majority of patients with chest pain, an acute coronary syndrome (ACS) can be ruled out. However, early recognition of an ACS is required in order to start treatment as soon as possible and reduce risks associated with myocardial ischaemia. Because of the lack of pre-hospital protocols to rule out an ACS, patients with a suspected ACS are transported to the emergency department, where the HEART score can be used to estimate the risk of major adverse cardiac events (MACE). Patients with a low HEART score have a low risk of MACE. A point-of-care (POC) troponin measurement enables ambulance paramedics to calculate the HEART score in the pre-hospital setting. POC troponin measurement and HEART score assessment have several potential advantages, including early recognition of an ACS and identification of high-risk patients before hospital arrival. Moreover, pre-hospital rule-out of an ACS could prevent unnecessary emergency department visits. The safety and cost-effectiveness of referring low-risk patients with a normal POC troponin value to the general practitioner are currently being investigated in the ARTICA randomised trial. This point-of-view article demonstrates one of the potential advantages of early detection of an ACS.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...